NEWS & EVENTS

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced that it will present at the upcoming SupplySide West conference in Las Vegas.

Catalent, a global leader in clinical supply services, today announced that Guy J. Dewil, M.D. has been appointed General Manager of its clinical supply facility in Schorndorf, Germany.

Catalent today announced it will present at the 9th Partnership Opportunities in Drug Delivery (PODD) annual conference at the Renaissance Boston Waterfront Hotel, Boston, on Oct. 7 – 8, 2019.

CADDI today announced that along with Columbia University’s Lab-to-Market Accelerator Network and the Translational Therapeutics Accelerator (TRx), it will co-host a one-day symposium titled “Smart Drug Development & Design” at Columbia University.

Catalent and Minerva Neurosciences, Inc. today announced that they have entered into a long-term commercial supply agreement for roluperidone, an investigational compound for the treatment of schizophrenia.

Catalent today announced that Julie Delaney, Director, Project and Clinical Supplies Management, Asia Pacific (APAC) will present at the upcoming 3rd Annual Accelerating Clinical Trials in Asia on Sept. 25 – 26, 2019.

Catalent, today announced that professor David Schaffer has been appointed to the advisory board of the company’s biologics business.

Catalent today announced that Alex Haig, Senior Director, Engineering will present at the Pharma Forum, to be held at the Bausparkasse Schwäbisch Hall AG, Schwabisch Hall, Germany, on Sept. 18 – 19, 2019.

Catalent today announced it is to invest $9 million in a new clinical supply facility in San Diego, due to open in the summer of 2020.